Business Standard
The government has granted in-principle approval for a price increase in two key cancer medicines as soaring platinum costs disrupt production and supplies
Go to News Site
India Today
India Today
India Today
India Today
India Today
The Hindu
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard